InvestorsHub Logo
Followers 0
Posts 42
Boards Moderated 0
Alias Born 05/11/2011

Re: None

Monday, 07/09/2012 9:13:24 AM

Monday, July 09, 2012 9:13:24 AM

Post# of 125
Medgenics Inc (NYSE:MDGN) chief executive Dr. Andrew Pearlman claims its Biopump technology could possibly “start a whole new pharmaceutical industry. Our technology has promise to provide a major change in medicine. It is not just a product that we have, it’s an industry.” The technology manipulates the tissue of the patients themselves in order to produce proteins which fight diseases. This will eliminate the necessity for hundreds of vaccines. Shares of Medgenics Inc are trading 6.67% lower today.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.